{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:13:18Z","timestamp":1771423998205,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-26332-5","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:24:18Z","timestamp":1769523858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of insulin injection-induced lipohypertrophy detected by ultrasound: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Qin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"26332_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: rlobal, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109\u201319.","journal-title":"Diabetes Res Clin Pract"},{"issue":"02","key":"26332_CR2","first-page":"79105","volume":"09","author":"LN Ji","year":"2017","unstructured":"Ji LN, Guo XH, Huang J, et al. Technical guidelines for injection of diabetes drugs in China (2016 Edition). Chin J Diabetes. 2017;09(02):79105.","journal-title":"Chin J Diabetes"},{"issue":"5","key":"26332_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","volume":"39","author":"M Blanco","year":"2013","unstructured":"Blanco M, Hernandez MT, Strauss KW, et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445\u201353.","journal-title":"Diabetes Metab"},{"issue":"5","key":"26332_CR4","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1007\/s12325-022-02105-5","volume":"39","author":"S Gentile","year":"2022","unstructured":"Gentile S, Guarino G, Della CT, et al. The economic burden of insulin Injection-Induced Lipohypertophy. Role of education: the ISTERP-3 study . Adv Ther. 2022;39(5):2192\u2013207.","journal-title":"Adv Ther"},{"key":"26332_CR5","unstructured":"Yu J, Wang H, Shi Y et al. Relationship between subcutaneous lipohypertrophy by insulin injection and multidimensional self-management in patients with type 1 diabetes mellitus. Chin J Diabetes, 2021,\u200213(9): 897\u2013900."},{"issue":"2","key":"26332_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13410-020-00889-2","volume":"41","author":"R Kumar","year":"2021","unstructured":"Kumar R, Guptar D, Shetty S, et al. Lipohypertrophy in insulin injecting patients with diabetes mellitus: an under-recognized barrier for glycemic control. Int J Diabetes Developing Ctries. 2021;41(2):329\u201336.","journal-title":"Int J Diabetes Developing Ctries"},{"key":"26332_CR7","doi-asserted-by":"crossref","unstructured":"Thewjitcharoen Y, Prasartkaew H, Tongsumrit P, et al. Prevalence, risk Factors, and clinical characteristics of lipodystrophy in Insulin-Treated patients with diabetes: an old problem in a new era of modern Insulin. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy; 2020. pp. 4609\u201320.","DOI":"10.2147\/DMSO.S282926"},{"issue":"11","key":"26332_CR8","first-page":"1578","volume":"36","author":"G Li","year":"2021","unstructured":"Li G, Li W, Li J, et al. Meta-analysis of incidence of subcutaneous lipohypertrophy in in diabetic patients. West China Med J. 2021;36(11):1578\u201384.","journal-title":"West China Med J"},{"issue":"6","key":"26332_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.therap.2021.04.002","volume":"76","author":"K Wang","year":"2021","unstructured":"Wang K, Zhang S, Liu C, et al. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy. Therapies. 2021;76(6):617\u201328.","journal-title":"Therapies"},{"key":"26332_CR10","unstructured":"Yan D, Zhu M, Wu Y et al. Analysis of influencing factors of subcutaneous lipohypertrophy induced by insulin injection based on ultrasonic precision detection. Chin J Diabetes, 2021,\u200229(10): 738\u201341."},{"issue":"5","key":"26332_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s13300-018-0472-7","volume":"9","author":"HA Ghazaleh","year":"2018","unstructured":"Ghazaleh HA, Hashem R, Forbes A, et al. A systematic review of ultrasound-detected lipohypertrophy in insulin-exposed people with diabetes. Diabetes Ther. 2018;9(5):1741\u201356.","journal-title":"Diabetes Ther"},{"key":"26332_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jclinepi.2018.01.007","volume":"98","author":"R Chou","year":"2018","unstructured":"Chou R, Baker WL, Banez LL, et al. Agency for Healthcare Research and Quality evidence-based practice center methods provide guidance on prioritization and selection of harms in systematic reviews. J Clin Epidemiol. 2018;98:98\u2013104.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"26332_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12020-021-02904-w","volume":"75","author":"Y Lin","year":"2022","unstructured":"Lin Y, Lin Y, Wang W, et al. Insulin-related lipohypertrophy: ultrasound characteristics, risk factors, and impact of glucose fluctuations. Endocrine. 2022;75(3):768\u201375.","journal-title":"Endocrine"},{"issue":"29","key":"26332_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026743","volume":"100","author":"W Wang","year":"2021","unstructured":"Wang W, Huang R, Chen Y, et al. Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: a prospective cohort study in China. Medicine Baltimore. 2021;100(29):e26743.","journal-title":"Medicine Baltimore"},{"issue":"10","key":"26332_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/dme.13764","volume":"35","author":"JE Kapeluto","year":"2018","unstructured":"Kapeluto JE, Paty BW, Chang SD, et al. Ultrasound detection of insulin-induced lipohypertrophy in type1 and type 2 diabetes. Diabet Med. 2018;35(10):1383\u201390.","journal-title":"Diabet Med"},{"issue":"3","key":"26332_CR16","doi-asserted-by":"publisher","first-page":"107806","DOI":"10.1016\/j.jdiacomp.2020.107806","volume":"35","author":"D Luo","year":"2021","unstructured":"Luo D, Shi Y, Zhu M, et al. Subclinical lipohypertrophy\u2014\u2014Easily ignored complications of insulin therapy. J Diabetes Complicat. 2021;35(3):107806.","journal-title":"J Diabetes Complicat"},{"issue":"9","key":"26332_CR17","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","volume":"11","author":"S Gentile","year":"2020","unstructured":"Gentile S, Guarino G, Della Corte T, et al. Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in southern Italy. Diabetes Ther. 2020;11(9):2001\u201317.","journal-title":"Diabetes Ther"},{"issue":"2","key":"26332_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.eprac.2022.11.008","volume":"29","author":"T Barlas","year":"2023","unstructured":"Barlas T, Yalcin MM, Coskun M, et al. Evaluation of lipohypertrophy in patients with type 1 diabetes mellitus on multiple daily insulin injections or continuous subcutaneous insulin infusion. Endocr Pract. 2023;29(2):119\u201326.","journal-title":"Endocr Pract"},{"issue":"5","key":"26332_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.pcd.2021.06.004","volume":"15","author":"S Arora","year":"2021","unstructured":"Arora S, Agrawal NK, Shanthaiah DM, et al. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Prim Care Diabetes. 2021;15(5):859\u201364.","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"26332_CR20","first-page":"354","volume":"69","author":"FN Korkmaz","year":"2022","unstructured":"Korkmaz FN, Canpolat AG, Guttu S. Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes. Endocrinol Diabetes Nutr (Engl Ed). 2022;69(5):354\u201361.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"3","key":"26332_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/CM9.0000000000001742","volume":"135","author":"J Yu","year":"2021","unstructured":"Yu J, Wang H, Zhu M, et al. Detection sensitivity of ultrasound scanning vs. clinical examination for insulin injection-related lipohypertrophy. Chin Med J (Engl). 2021;135(3):353\u20135.","journal-title":"Chin Med J (Engl)"},{"issue":"03","key":"26332_CR22","first-page":"236","volume":"39","author":"H Wang","year":"2023","unstructured":"Wang H, Yu J, Zhou M, et al. Correlation between subcutaneous lipohypertrophy and multidimensional blood glucose fluctuations in insulin injection in patients with type 1 diabetes mellitus. Inside China J Secret Metabolism. 2023;39(03):236\u201341.","journal-title":"Inside China J Secret Metabolism"},{"issue":"32","key":"26332_CR23","first-page":"62","volume":"29","author":"C Liu","year":"2022","unstructured":"Liu C, Chen Y, Zhou P, et al. Application of inspection, palpation combined with ultrasound technology in patients with subcutaneous lipohypertrophy. Chin Contemp Med. 2022;29(32):62\u20134.","journal-title":"Chin Contemp Med"},{"issue":"02","key":"26332_CR24","first-page":"206","volume":"36","author":"X Song","year":"2022","unstructured":"Song X, Wu H, Wu D, et al. Evaluation method and effect of subcutaneous lipohypertrophy insulin injection site in elderly diabetic patients. Practical Geriatr. 2022;36(02):206\u20138.","journal-title":"Practical Geriatr"},{"issue":"08","key":"26332_CR25","first-page":"809","volume":"13","author":"M Zhu","year":"2021","unstructured":"Zhu M, Wang H, Shen M, et al. Application of high-frequency ultrasound in clinical screening of subcutaneous lipohypertrophy by insulin injection. Chin J Diabetes. 2021;13(08):809\u201313.","journal-title":"Chin J Diabetes"},{"issue":"11","key":"26332_CR26","first-page":"1001","volume":"37","author":"Y Shi","year":"2021","unstructured":"Shi Y, Yu J, Wang H, et al. Effect of subcutaneous lipohypertrophy deep diameter by ultrasound insulin injection on glycemic control in diabetic patients. Chin J Endocrinol Metabolism. 2021;37(11):1001\u20133.","journal-title":"Chin J Endocrinol Metabolism"},{"issue":"39","key":"26332_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034696","volume":"102","author":"CO Kirac","year":"2023","unstructured":"Kirac CO, Sirikci V, Findikli HA. The impact of insulin induced lipohypertrophy on carotid intima-media thickness in patients with type 2 diabetes mellitus. Medicine (Baltimore). 2023;102(39):e34696.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"26332_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13300-022-01341-w","volume":"14","author":"S Gentile","year":"2023","unstructured":"Gentile S, Guarino G, Della Corte T, et al. Why do so many people with type 2 diabetes who take insulin have lipohypertrophy? Fate or educational Deficiencies?. Diabetes Ther. 2023;14(1):179\u201391.","journal-title":"Diabetes Ther"},{"issue":"9","key":"26332_CR29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/diagnostics13091515","volume":"13","author":"J Yu","year":"2023","unstructured":"Yu J, Wang H, Zhou M, et al. A hypothesis on the progression of Insulin-Induced lipohypertrophy: an integrated result of High-Frequency ultrasound imaging and blood glucose control of Patients. Diagnostics (Basel). 2023;13(9):1515. Published 2023 Apr 23.","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"26332_CR30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3760\/cma.j.cn115791-20240214-00067","volume":"16","author":"FM Cheng","year":"2024","unstructured":"Cheng FM, Yu ST, Zhang JN, et al. Correlation between insulin injection site temperature and subcutaneous lipohypertrophy in patients with type 2 diabetes mellitus. Chin J Diabetes. 2024;16(11):1240\u20136. https:\/\/doi.org\/10.3760\/cma.j.cn115791-20240214-00067.","journal-title":"Chin J Diabetes"},{"issue":"3","key":"26332_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15458","volume":"42","author":"H Xu","year":"2025","unstructured":"Xu H, Cheng Z, Li X, et al. Comparison of ultrasound scanning and clinical examination for detecting insulin injection related lipohypertrophy and construction of lipohypertrophy classification table. Diabet Med. 2025;42(3):e15458.","journal-title":"Diabet Med"},{"key":"26332_CR32","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S443737","author":"ZH Sun","year":"2024","unstructured":"Sun ZH, Yu CH, Wang X. Exploring the diagnostic value of high-frequency ultrasound technology for subcutaneous lipohypertrophy in diabetes patients receiving insulin injections. Diabetes Metab Syndr Obes. 2024. https:\/\/doi.org\/10.2147\/DMSO.S443737.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"26332_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/diabetology5070053","volume":"5","author":"S Gentile","year":"2024","unstructured":"Gentile S, Strollo F, Guarino G, et al. Insulin-Related skin lipohypertrophy in type two diabetes: A clinical study of a case Series, with ultrasonographic and histopathologic Implications. Diabetology. 2024;5(7):725\u201342.","journal-title":"Diabetology"},{"key":"26332_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70034","author":"J Yu","year":"2025","unstructured":"Yu J, Wang H, Zhou M, et al. Impact of ultrasound-diagnosed lipohypertrophy subtypes on insulin regimen adjustments in patients with T1DM. Diabet Med. 2025. https:\/\/doi.org\/10.1111\/dme.70034.","journal-title":"Diabet Med"},{"issue":"06","key":"26332_CR35","first-page":"665","volume":"41","author":"Diabetes Branch of Chinese Medical Association","year":"2021","unstructured":"Diabetes Branch of Chinese Medical Association. Chinese expert consensus on the prevention and treatment of subcutaneous lipohypertrophy associated with insulin injection. Int J Endocrinol Metabolism. 2021;41(06):665\u201372.","journal-title":"Int J Endocrinol Metabolism"},{"key":"26332_CR36","doi-asserted-by":"publisher","unstructured":"Xu XH. Effect of injection education interval on patients with diabetes using insulin[D]. Nanjing:Southeast University, 2020. https:\/\/doi.org\/10.27014\/d.cnki.gdnau.2020.004217","DOI":"10.27014\/d.cnki.gdnau.2020.004217"},{"issue":"06","key":"26332_CR37","first-page":"56","volume":"33","author":"YQ Shi","year":"2018","unstructured":"Shi YQ, Sun HL. Analysis of subcutaneous lipohypertrophy and its influencing factors in patients with insulin self-injection. J Nurs. 2018;33(06):56\u20139.","journal-title":"J Nurs"},{"key":"26332_CR38","unstructured":"Diabetes Branch of Chinese Medical Association, Endocrinology and Metabolism Physician Branch of Chinese Medical Doctor Association, Endocrinology Branch of Chinese Medical Association, et al. Chinese type 1 glycosuria Guidelines for the diagnosis and treatment of diseases (2021 edition). Chinese Journal of Diabetes et al. 2022, 14(11):1143\u20131250."},{"key":"26332_CR39","doi-asserted-by":"publisher","first-page":"j5295","DOI":"10.1136\/bmj.j5295","volume":"360","author":"J Weng","year":"2018","unstructured":"Weng J, Zhou Z, Guo L, et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018;360:j5295.","journal-title":"BMJ"},{"issue":"04","key":"26332_CR40","first-page":"315","volume":"13","author":"Diabetes Branch of Chinese Medical Association","year":"2021","unstructured":"Diabetes Branch of Chinese Medical Association. Guidelines for the prevention and treatment of type 2 diabetes in China (2020 edition). Chin J Diabetes. 2021;13(04):315\u2013409.","journal-title":"Chin J Diabetes"},{"issue":"07","key":"26332_CR41","first-page":"18","volume":"15","author":"LH Lian","year":"2018","unstructured":"Lian LH, Fu JL, Feng LY. Status quo and related factors of subcutaneous lipohypertrophy in diabetic insulin injection patients. Nurs Pract Res. 2018;15(07):18\u201320.","journal-title":"Nurs Pract Res"},{"key":"26332_CR42","doi-asserted-by":"publisher","first-page":"110598","DOI":"10.1016\/j.diabres.2023.110598","volume":"198","author":"P Salpea","year":"2023","unstructured":"Salpea P, Huang YD, Genitsaridi I, et al. Call for data contribution to the 11th edition of idf\u2019s diabetes Atlas(2024). Diabetes Res Clin Pract. 2023;198:110598.","journal-title":"Diabetes Res Clin Pract"},{"key":"26332_CR43","unstructured":"Zhang Q, Jia P, Wang L, et al. Meta-analysis of factors associated with subcutaneous Lipohypertrophy induced by insulin injection. Evidence-based Nursing, 2023, 9(24):4402\u20134408."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-26332-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-26332-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:41:39Z","timestamp":1771422099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-26332-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26332"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-26332-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary literature research and does not involve informed consent from research subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This systematic review and meta-analysis is based on previously published studies, and no new human participants or individual-level data were collected. Therefore, consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"663"}}